[go: up one dir, main page]

CN110507844A - A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose - Google Patents

A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose Download PDF

Info

Publication number
CN110507844A
CN110507844A CN201910842260.6A CN201910842260A CN110507844A CN 110507844 A CN110507844 A CN 110507844A CN 201910842260 A CN201910842260 A CN 201910842260A CN 110507844 A CN110507844 A CN 110507844A
Authority
CN
China
Prior art keywords
bacteria cellulose
bacterial cellulose
preparation
oxidizing bacteria
composite material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910842260.6A
Other languages
Chinese (zh)
Inventor
洪枫
袁海彬
陈琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN201910842260.6A priority Critical patent/CN110507844A/en
Publication of CN110507844A publication Critical patent/CN110507844A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418Agents promoting blood coagulation, blood-clotting agents, embolising agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明涉及一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合材料及其制备方法,通过以细菌纤维素为底物制备氧化细菌纤维素,再与多聚阳离子电解质进行复合;或者通过以细菌纤维素为底物制备氧化细菌纤维素,再与多聚阳离子电解质进行静电吸附自组装,并对凝血促愈因子进行包裹负载而得。本发明同时具备急性止血、广谱抗菌、促进愈合及体内吸收的特性;制备方法绿色环保,复合均匀高效,得到的复合材料安全性高,在高级功能敷料领域具有良好的市场应用前景。

The present invention relates to an absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose and a preparation method thereof. The oxidized bacterial cellulose is prepared by using bacterial cellulose as a substrate, and then compounded with a polycationic electrolyte; or It is obtained by preparing oxidized bacterial cellulose with bacterial cellulose as a substrate, then electrostatically adsorbing and self-assembling with polycationic electrolytes, and wrapping and loading blood coagulation-promoting factors. The invention has the characteristics of acute hemostasis, broad-spectrum antibacterial, healing promotion and in vivo absorption; the preparation method is green and environmentally friendly, the compound is uniform and efficient, and the obtained composite material has high safety, and has good market application prospects in the field of advanced functional dressings.

Description

一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合 材料及其制备方法An Absorbable Compound Based on Oxidized Bacterial Cellulose for Local Acute Hemostasis Materials and their preparation methods

技术领域technical field

本发明属于生物医用复合材料技术领域,特别涉及一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合材料及其制备方法。The invention belongs to the technical field of biomedical composite materials, in particular to an absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose and a preparation method thereof.

背景技术Background technique

可吸收止血材料是一种用于伤口出血部位,能够快速止血,并且在一定时间内能被人体吸收的生物医用材料。其最大特点在于:应用于人体或动物体内局部难缝合伤口止血,在实现快速止血的同时,可在体内降解、无需取出,从而避免止血完成后去除敷料的二次伤害。目前常用的可吸收止血材料有纤维蛋白胶类止血材料、明胶海绵类止血材料、氧化纤维素类止血材料及壳聚糖类止血材料等。这些止血材料的止血机理和使用方法各不相同,其止血效果也有很大差别。Absorbable hemostatic material is a kind of biomedical material that can stop bleeding quickly and can be absorbed by the human body within a certain period of time. Its biggest feature is that it is applied to local wounds in humans or animals that are difficult to suture to stop bleeding. While achieving rapid hemostasis, it can be degraded in the body without taking it out, so as to avoid secondary damage caused by removing the dressing after hemostasis is completed. At present, commonly used absorbable hemostatic materials include fibrin glue-based hemostatic materials, gelatin sponge-based hemostatic materials, oxidized cellulose-based hemostatic materials, and chitosan-based hemostatic materials. The hemostatic mechanisms and usage methods of these hemostatic materials are different, and their hemostatic effects are also very different.

氧化再生纤维素(Oxidized Regenerated Cellulose,ORC)在1960年首次制备成功,是植物纤维素经再生后氧化处理成为纤维素酸的薄纱状或棉布状可吸收止血材料,具有棉纱的外观和质地,柔软而菲薄,易于包、敷、填塞等操作。其止血机制是将手术创面血液中的血小板聚集在网眼纱布上,以止血纱布作为止血基质,遇血后迅速形成凝胶状黑色物质,凝结血块从而达到止血的目的。它不依赖于人体内正常的凝血机制,而是通过物理作用迅速促使血液凝固,有效控制小血管出血。目前,只有美国和英国能生产该类产品,临床上使用的可吸收止血纱布Surgicel(速即纱)就是美国强生公司的产品。速即纱的主要成分就是氧化再生纤维素。氧化再生纤维素将纤维素中的C6伯羟基高度选择性氧化成为羧基而得到的纤维素的一种衍生物,目前已被应用于各行各业,且市场销售的产品主要依赖于进口,国内仅有几家公司生产出了类似的止血纱布。虽然氧化再生纤维素有很多优异的性能,但也存在一些弊端,如止血效率不高,不能适用于大量出血,抗菌性能弱以及组织相容性低等。Oxidized Regenerated Cellulose (ORC) was successfully prepared for the first time in 1960. It is a gauze-like or cotton-like absorbable hemostatic material made of cellulose acid after plant cellulose is oxidized after regeneration. It has the appearance and texture of cotton yarn. Soft and thin, easy to pack, apply, stuff and other operations. Its hemostatic mechanism is to gather the platelets in the surgical wound blood on the mesh gauze, use the hemostatic gauze as the hemostatic matrix, and quickly form a gel-like black substance when it encounters blood, and coagulate the blood clot to achieve the purpose of hemostasis. It does not rely on the normal blood coagulation mechanism in the human body, but rapidly promotes blood coagulation through physical action, effectively controlling bleeding in small blood vessels. At present, only the United States and the United Kingdom can produce such products, and the clinically used absorbable hemostatic gauze Surgicel is a product of Johnson & Johnson of the United States. The main component of instant yarn is oxidized regenerated cellulose. Oxidized regenerated cellulose is a derivative of cellulose obtained by highly selective oxidation of C6 primary hydroxyl groups in cellulose to carboxyl groups. It has been used in various industries, and the products sold in the market mainly rely on imports. Several companies make similar hemostatic gauzes. Although oxidized regenerated cellulose has many excellent properties, there are also some disadvantages, such as low hemostatic efficiency, not suitable for massive bleeding, weak antibacterial properties and low tissue compatibility.

目前,在一些公开或授权的发明专利中,已经使用天然/合成高分子材料或者无机材料对氧化再生纤维素进行改性来提高其抗菌和止血性能。如胶原蛋白(CN105079886A)、藻酸盐(CN104013991A)和碳纳米管(CN105056284A)等。虽然以上复合止血材料对氧化再生纤维素性能有了一定的提升,但是改善效果较差,只能提升其部分性能,并且会对材料的生物可吸收性能造成负面影响。At present, in some published or authorized invention patents, natural/synthetic polymer materials or inorganic materials have been used to modify oxidized regenerated cellulose to improve its antibacterial and hemostatic properties. Such as collagen (CN105079886A), alginate (CN104013991A) and carbon nanotubes (CN105056284A). Although the above composite hemostatic materials have improved the performance of oxidized regenerated cellulose to a certain extent, the improvement effect is poor, and only part of its performance can be improved, and it will have a negative impact on the bioabsorbability of the material.

发明内容Contents of the invention

本发明所要解决的技术问题是提供一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合材料及其制备方法,解决了氧化再生纤维素抗菌性能弱、组织相容性低、止血速度慢的问题。The technical problem to be solved by the present invention is to provide an absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose and its preparation method, which solves the problems of weak antibacterial properties of oxidized regenerated cellulose, low tissue compatibility, and hemostasis speed. slow problem.

本发明提供了一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合材料,通过以细菌纤维素为底物制备氧化细菌纤维素,再与多聚阳离子电解质进行复合;或者通过以细菌纤维素为底物制备氧化细菌纤维素,再与多聚阳离子电解质进行静电吸附自组装,并对凝血促愈因子进行包裹负载而得。The invention provides an absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose, which is prepared by using bacterial cellulose as a substrate to prepare oxidized bacterial cellulose, and then compounding it with polycationic electrolytes; or by using bacterial cellulose The cellulose is used as a substrate to prepare oxidized bacterial cellulose, which is then self-assembled by electrostatic adsorption with a polycationic electrolyte, and the coagulation-promoting factor is packaged and loaded.

所述氧化细菌纤维素通过以细菌纤维素为基材,经碱纯化并用去离子水漂洗至中性后获得。The oxidized bacterial cellulose is obtained by using bacterial cellulose as a base material, purifying with alkali and rinsing with deionized water until neutral.

所述多聚阳离子电解质包括壳聚糖、聚赖氨酸、季铵盐类中的一种或几种;凝血促愈因子包括凝血酶、胶原蛋白中的一种或几种。The polycationic electrolyte includes one or more of chitosan, polylysine, and quaternary ammonium salts; the blood coagulation promoting factor includes one or more of thrombin and collagen.

本发明还提供了一种基于氧化细菌纤维素的用于局部急性止血的可吸收复合材料的制备方法,包括:The present invention also provides a method for preparing an absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose, comprising:

(1)以细菌纤维素为底物,制备氧化细菌纤维素悬浊液;(1) using bacterial cellulose as a substrate to prepare an oxidized bacterial cellulose suspension;

(2)将多聚阳离子电解质溶液逐滴加入到氧化细菌纤维素悬浊液中进行静电吸附自组装反应,然后取出,漂洗,冻干,得到局部急性止血可吸收材料;(2) adding the polycation electrolyte solution dropwise into the oxidized bacterial cellulose suspension to carry out electrostatic adsorption self-assembly reaction, then taking it out, rinsing, and freeze-drying to obtain a local acute hemostasis absorbable material;

或者,将凝血促愈因子加入到氧化细菌纤维素悬浊液中浸渍吸附,再将多聚阳离子电解质溶液逐滴加入到氧化细菌纤维素悬浊液中进行静电吸附自组装反应,然后取出,漂洗,冻干,得到局部急性止血可吸收材料。Alternatively, the coagulation-promoting factor is added to the oxidized bacterial cellulose suspension for impregnation and adsorption, and then the polycation electrolyte solution is added dropwise to the oxidized bacterial cellulose suspension for electrostatic adsorption self-assembly reaction, and then taken out and rinsed , freeze-dried to obtain local acute hemostasis absorbable material.

所述步骤(1)中的氧化细菌纤维素悬浊液的制备步骤如下:将细菌纤维素膜打散,经TEMPO/NaBr/NaClO混合氧化体系于室温下氧化,离心清洗和透析后得到。The preparation steps of the oxidized bacterial cellulose suspension in the step (1) are as follows: the bacterial cellulose film is broken up, oxidized at room temperature by a TEMPO/NaBr/NaClO mixed oxidation system, and obtained after centrifugal cleaning and dialysis.

所述步骤(2)中的多聚阳离子电解质溶液为1-5%的壳聚糖/稀酸溶液、0.1-1%的聚赖氨酸水溶液或者1-10%的有机硅季铵盐水溶液。The polycation electrolyte solution in the step (2) is 1-5% chitosan/dilute acid solution, 0.1-1% polylysine aqueous solution or 1-10% organic silicon quaternary ammonium salt aqueous solution.

所述步骤(2)中的凝血促愈因子为0.1-10mg/mL胶原蛋白水溶液或者0.01-1mg/mL的凝血酶。The coagulation-promoting factor in the step (2) is 0.1-10 mg/mL collagen aqueous solution or 0.01-1 mg/mL thrombin.

所述步骤(2)中的凝血促愈因子与氧化细菌纤维素的质量比为1:1-10:1。The mass ratio of the blood coagulation promoting factor to the oxidized bacterial cellulose in the step (2) is 1:1-10:1.

所述步骤(2)中的浸渍吸附时间为0.5-5小时。The soaking and adsorption time in the step (2) is 0.5-5 hours.

所述步骤(2)中的静电吸附自组装反应时间为1-60分钟。The electrostatic adsorption self-assembly reaction time in the step (2) is 1-60 minutes.

本发明以细菌纳米纤维素为底物制备氧化细菌纤维素(OBC),利用其高纯度和大比表面积特性,加快凝血过程。同时利用OBC和多聚阳离子电解质相反的电荷性,进行静电吸附自组装反应进行复合,还可以在其中引入凝血促愈因子,制备得到同时具有急性止血、抗菌和促愈功能的可吸收复合材料。The invention uses bacterial nanocellulose as a substrate to prepare oxidized bacterial cellulose (OBC), and utilizes its high purity and large specific surface area characteristics to accelerate the coagulation process. At the same time, the opposite charge of OBC and polycationic electrolyte is used to carry out electrostatic adsorption self-assembly reaction for compounding, and blood coagulation promoting healing factors can also be introduced into it to prepare an absorbable composite material with acute hemostatic, antibacterial and healing-promoting functions.

有益效果Beneficial effect

(1)本发明材料以细菌纤维素为底物制备氧化细菌纤维素,其羧基含量更高,纳米尺度纤维,比表面积更大,聚合度更低,止血效果更好,生物可降解性能更好,更容易被人体吸收。(1) The material of the present invention uses bacterial cellulose as a substrate to prepare oxidized bacterial cellulose, which has higher carboxyl content, nanoscale fibers, larger specific surface area, lower degree of polymerization, better hemostatic effect, and better biodegradability , more easily absorbed by the body.

(2)本发明利用氧化细菌纤维素与多聚阳离子电解质相反的电荷性进行静电吸附自组装制备,无需使用额外交联剂;同时,多聚阳离子电解质的加入提高了材料促凝血和抗菌特性。(2) The present invention utilizes the opposite charge of oxidized bacterial cellulose and polycationic electrolyte to carry out electrostatic adsorption self-assembly preparation without using additional cross-linking agent; at the same time, the addition of polycationic electrolyte improves the procoagulant and antibacterial properties of the material.

(3)本发明通过利用氧化细菌纤维素大的比表面积,在充分吸附凝血促愈因子之后再与多聚阳离子电解质进行静电吸附自组装反应,最终得到的材料同时具备急性止血、抗菌、促愈和可吸收的特性。(3) By utilizing the large specific surface area of oxidized bacterial cellulose, the present invention conducts electrostatic adsorption self-assembly reaction with polycationic electrolytes after fully absorbing coagulation-promoting factors. and absorbable properties.

(4)本发明原料均为绿色环保生物材料,不含对人体有害的化学物质,可根据实际情况和特点制备成各种形状,安全环保,丢弃后在环境中能迅速降解,可作为一种性能良好且绿色环保的功能性材料。(4) The raw materials of the present invention are all green environmental protection biological materials, do not contain harmful chemical substances to the human body, can be prepared into various shapes according to actual conditions and characteristics, are safe and environmentally friendly, and can be rapidly degraded in the environment after being discarded, and can be used as a Functional materials with good performance and green environmental protection.

(5)本发明制备方法简单易行,复合均匀高效,不使用交联剂,不会对合成物质的原有结构造成破坏,绿色环保,可工业化生产,具有良好的市场应用前景。(5) The preparation method of the present invention is simple and easy to perform, uniform and efficient in compounding, does not use a crosslinking agent, does not cause damage to the original structure of the synthetic material, is environmentally friendly, can be industrialized, and has a good market application prospect.

附图说明Description of drawings

图1为本发明制备方法的流程示意图;Fig. 1 is the schematic flow sheet of preparation method of the present invention;

图2为实施例1-6所制备材料的产品图;其中,1为氧化细菌纤维素(OBC),2为氧化细菌纤维素/壳聚糖(OBC/CS),3为氧化细菌纤维素/胶原蛋白/壳聚糖(OBC/COL/CS),4为氧化细菌纤维素/聚赖氨酸(OBC/PL),5为氧化细菌纤维素/有机硅季铵盐(OBC/SQA),6为氧化细菌纤维素/凝血酶/聚赖氨酸(OBC/TB/PL);Fig. 2 is the product diagram of the prepared material of embodiment 1-6; Wherein, 1 is oxidized bacterial cellulose (OBC), 2 is oxidized bacterial cellulose/chitosan (OBC/CS), 3 is oxidized bacterial cellulose/ Collagen/chitosan (OBC/COL/CS), 4 is oxidized bacterial cellulose/polylysine (OBC/PL), 5 is oxidized bacterial cellulose/organosilicon quaternary ammonium salt (OBC/SQA), 6 Oxidized bacterial cellulose/thrombin/polylysine (OBC/TB/PL);

图3是实施例1-6所制备材料的体外全血凝固时间测试结果。Fig. 3 is the in vitro whole blood coagulation time test results of the materials prepared in Examples 1-6.

具体实施方式Detailed ways

下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

实施例1Example 1

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜。(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid.

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)将步骤(3)得到的氧化细菌纤维素悬浊液进行冷冻干燥,最后得到氧化细菌纤维素止血材料。(4) Freeze-drying the oxidized bacterial cellulose suspension obtained in step (3) to finally obtain the oxidized bacterial cellulose hemostatic material.

实施例2Example 2

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid;

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)称取2g壳聚糖充分溶解于100mL 3%的醋酸溶液中,形成终浓度为2%的壳聚糖稀酸溶液。(4) Take 2g of chitosan and fully dissolve it in 100mL of 3% acetic acid solution to form a dilute chitosan acid solution with a final concentration of 2%.

(5)取5mL步骤(4)制备的壳聚糖稀酸溶液逐滴加入50mL步骤(3)制备的氧化细菌纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化细菌纤维素/壳聚糖复合止血材料。(5) Get the dilute chitosan acid solution prepared by 5mL step (4) and add dropwise in the oxidized bacterial cellulose suspension prepared by 50mL step (3), after reacting for 60 minutes, the product was repeatedly centrifuged and rinsed, and finally freeze-dried, The oxidized bacterial cellulose/chitosan composite hemostatic material was obtained.

实施例3Example 3

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid;

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)称取30mg的鱼源胶原蛋白充分溶解于10mL无菌水中,形成终浓度为3mg/mL的蛋白溶液。(4) Weigh 30 mg of fish-derived collagen and fully dissolve it in 10 mL of sterile water to form a protein solution with a final concentration of 3 mg/mL.

(5)取10mL步骤(4)制备的蛋白溶液加入40mL步骤(3)制备的氧化细菌纤维素悬浊液中,充分搅拌吸附1小时,得到吸附有胶原蛋白的氧化细菌纤维素悬浊液。(5) Add 10 mL of the protein solution prepared in step (4) to 40 mL of the oxidized bacterial cellulose suspension prepared in step (3), stir and absorb for 1 hour to obtain the oxidized bacterial cellulose suspension with collagen adsorbed thereon.

(6)称取2g壳聚糖充分溶解于100mL 3%的醋酸溶液中,形成终浓度为2%的壳聚糖稀酸溶液。(6) Take 2g of chitosan and fully dissolve it in 100mL of 3% acetic acid solution to form a dilute chitosan acid solution with a final concentration of 2%.

(7)取5mL步骤(6)制备的壳聚糖稀酸溶液逐滴加入50mL步骤(5)制备的吸附有胶原蛋白的氧化细菌纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化细菌纤维素/胶原蛋白/壳聚糖复合止血材料。(7) get the chitosan dilute acid solution that 5mL step (6) prepares and add dropwise in the oxidized bacterial cellulose suspension that the absorption of collagen protein is prepared in 50mL step (5), after reacting for 60 minutes, the product is repeatedly centrifuged and rinsed, Finally, freeze-drying is carried out to obtain the oxidized bacterial cellulose/collagen/chitosan composite hemostatic material.

实施例4Example 4

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid;

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)称取0.2g壳聚糖充分溶解于100mL无菌水中,形成终浓度为0.2%的聚赖氨酸水溶液。(4) Weigh 0.2g chitosan and fully dissolve it in 100mL sterile water to form a polylysine aqueous solution with a final concentration of 0.2%.

(5)取5mL步骤(4)制备的聚赖氨酸水溶液逐滴加入50mL步骤(3)制备的氧化细菌纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化细菌纤维素/聚赖氨酸复合止血材料。(5) Add 5 mL of the polylysine aqueous solution prepared in step (4) dropwise to the oxidized bacterial cellulose suspension prepared in 50 mL of step (3), react for 60 minutes and then centrifuge and rinse the product repeatedly, and finally freeze-dry it. The oxidized bacterial cellulose/polylysine composite hemostatic material was obtained.

实施例5Example 5

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid;

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)称取0.1g有机硅季铵盐充分溶解于100mL无菌水中,形成终浓度为0.1%的有机硅季铵盐水溶液。(4) Weigh 0.1 g of the organosilicon quaternary ammonium salt and fully dissolve it in 100 mL of sterile water to form an aqueous solution of the organosilicon quaternary ammonium salt with a final concentration of 0.1%.

(5)取5mL步骤(4)制备的有机硅季铵盐水溶液逐滴加入50mL步骤(3)制备的氧化细菌纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化细菌纤维素/有机硅季铵盐复合止血材料。(5) Add 5 mL of the organic silicon quaternary ammonium salt aqueous solution prepared in step (4) dropwise to 50 mL of the oxidized bacterial cellulose suspension prepared in step (3), react for 60 minutes, and repeatedly centrifuge and rinse the product, and finally freeze-dry , to obtain the oxidized bacterial cellulose/organosilicon quaternary ammonium salt composite hemostatic material.

实施例6Example 6

(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) With Acetobacter xylinum as the strain, after static culture in liquid medium at constant temperature for 10 days, the bacterial cellulose membrane was taken out and placed in sodium hydroxide solution, treated at 80°C for 2 hours, taken out, rinsed with deionized water until Obtain bacterial cellulose film after neutralization; soak in hyaluronic acid solution for 6 hours to obtain bacterial cellulose film soaked in hyaluronic acid;

(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, shred it and disperse it in a high-speed homogenizer to become a bacterial cellulose suspension.

(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化细菌纤维素悬浮液的羧基含量为23%。(3) The bacterial cellulose suspension obtained in step (2) (solid content is 1-10g/L) is oxidized at room temperature through TEMPO/NaBr/NaClO mixed oxidation system, TEMPO consumption is 0.1mmol/g, NaBr It is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and 0.5M NaOH solution was added dropwise to maintain the pH of the reaction system=10±0.5. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl content of the TEMPO oxidized bacterial cellulose suspension was determined to be 23% by conductometric titration.

(4)称取10mg的凝血酶充分溶解于10mL无菌水中,形成终浓度为1mg/mL的凝血酶溶液。(4) Weigh 10 mg of thrombin and fully dissolve it in 10 mL of sterile water to form a thrombin solution with a final concentration of 1 mg/mL.

(5)取10mL步骤(4)制备的凝血酶溶液加入40mL步骤(3)制备的氧化细菌纤维素悬浊液中,充分搅拌吸附1小时,得到吸附有凝血酶的氧化细菌纤维素悬浊液。(5) Take 10 mL of the thrombin solution prepared in step (4) and add it to 40 mL of the oxidized bacterial cellulose suspension prepared in step (3), fully stir and adsorb for 1 hour to obtain the oxidized bacterial cellulose suspension adsorbed with thrombin .

(6)称取0.2g聚赖氨酸充分溶解于100mL无菌水中,形成终浓度为0.2%的聚赖氨酸水溶液。(6) Weigh 0.2 g of polylysine and fully dissolve it in 100 mL of sterile water to form a polylysine aqueous solution with a final concentration of 0.2%.

(7)取5mL步骤(6)制备的聚赖氨酸水溶液逐滴加入50mL步骤(5)制备的吸附有凝血酶的氧化细菌纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化细菌纤维素/凝血酶/聚赖氨酸复合止血材料。(7) Get 5mL of the polylysine aqueous solution prepared in step (6) and add dropwise in the oxidized bacterial cellulose suspension prepared by 50mL of step (5) to absorb thrombin, react for 60 minutes and then centrifuge and rinse the product repeatedly, Finally, freeze-drying is carried out to obtain the composite hemostatic material of oxidized bacterial cellulose/thrombin/polylysine.

表1实施例1-6所制备材料对大肠杆菌、金黄色葡萄球菌和白色念珠菌的抗菌测试结果The antibacterial test result of the material prepared in the embodiment 1-6 of table 1 to escherichia coli, Staphylococcus aureus and Candida albicans

注:无菌纱布为对照组,测试方法依据ISO-20743—2007。Note: Sterile gauze is the control group, and the test method is based on ISO-20743-2007.

由表1可知,氧化细菌纤维素自身的确具有一定的抑菌作用,这主要是由于氧化细菌纤维素中大量羧基形成的低pH环境抑制了细菌的增殖和繁殖。但是其抑菌效果是非常有限的,无法完全避免细菌尤其耐酸性细菌和真菌对伤口的感染。相反,复合有多聚阳离子的实验组的抗菌性能较氧化细菌纤维素而言得到显著提升,并且对大肠杆菌、金黄色葡萄球菌和白色念珠菌具有相同抑菌趋势。优异的广谱抗菌性使得这一系列材料具有应用于临床的潜力。It can be seen from Table 1 that the oxidized bacterial cellulose itself does have a certain antibacterial effect, which is mainly due to the low pH environment formed by a large number of carboxyl groups in the oxidized bacterial cellulose, which inhibits the proliferation and reproduction of bacteria. However, its antibacterial effect is very limited, and it is impossible to completely avoid the infection of the wound by bacteria, especially acid-resistant bacteria and fungi. On the contrary, the antibacterial performance of the experimental group compounded with polycations was significantly improved compared with that of oxidized bacterial cellulose, and it had the same antibacterial tendency against Escherichia coli, Staphylococcus aureus and Candida albicans. The excellent broad-spectrum antibacterial properties make this series of materials have the potential for clinical application.

由图3可知,OBC的全血凝固时间分别为248s,而其他组复合材料的全血凝固时间都显著低于单一的OBC。尤其是复合有凝血促愈因子的实验组(实施例3和实施例6)凝血时间显著缩短,最短可至110s。其机理可能是由于氧化细菌纤维素,多聚阳离子以及凝血促愈因子三者的协同作用。本发明在不破坏原有结构的情况下将这三种功能材料巧妙地结合在一起,形成一种新的复合材料并获得优异的止血性能,有应用于临床作为急性止血材料的潜力。It can be seen from Figure 3 that the whole blood coagulation time of OBC is 248s, while the whole blood coagulation time of other composite materials is significantly lower than that of single OBC. In particular, the coagulation time of the experimental groups (Example 3 and Example 6) compounded with coagulation-promoting factors was significantly shortened, the shortest being as short as 110s. Its mechanism may be due to the synergistic effect of oxidized bacterial cellulose, polycations and coagulation-promoting factors. The invention skillfully combines these three functional materials without destroying the original structure to form a new composite material and obtain excellent hemostatic performance, which has the potential to be used clinically as an acute hemostatic material.

Claims (10)

1. a kind of absorbable composite material for topical acute hemostasis based on oxidizing bacteria cellulose, it is characterised in that: logical It crosses and prepares oxidizing bacteria cellulose by substrate of bacteria cellulose, then is compound with the progress of polycation electrolyte;Or pass through Oxidizing bacteria cellulose is prepared by substrate of bacteria cellulose, then carries out Electrostatic Absorption self assembly with polycation electrolyte, And the more factor is promoted to blood coagulation and carries out package load and obtains.
2. absorbable composite material according to claim 1, it is characterised in that: the oxidizing bacteria cellulose passes through with thin Fungin is substrate, is obtained after alkali purifies and is rinsed with deionized water to neutrality.
3. absorbable composite material according to claim 1, it is characterised in that: the polycation electrolyte includes shell One or more of glycan, polylysine, quaternary ammonium salt;Blood coagulation promotees to be cured the factor to include one of fibrin ferment, collagen Or it is several.
4. a kind of preparation method of the absorbable composite material for topical acute hemostasis based on oxidizing bacteria cellulose, packet It includes:
(1) using bacteria cellulose as substrate, oxidizing bacteria cellulose suspension is prepared;
(2) polycation electrolyte solution is added dropwise in oxidizing bacteria cellulose suspension and carries out Electrostatic Absorption from group Reaction cartridge then takes out, and rinses, and freeze-drying obtains the absorbable composite material to stop blooding for topical acute;
Alternatively, blood coagulation is promoted to be cured factor aqueous solution and be added in oxidizing bacteria cellulose suspension to impregnate absorption, then poly is positive Ionic electrolytes solution is added dropwise to progress Electrostatic Absorption self-assembling reaction in oxidizing bacteria cellulose suspension, then takes Out, it rinses, freeze-drying obtains the absorbable composite material to stop blooding for topical acute.
5. the preparation method according to claim 4, it is characterised in that: the oxidizing bacteria cellulose in the step (1) is outstanding The preparation step of turbid is as follows: bacteria cellulose film being broken up, at room temperature through TEMPO/NaBr/NaClO mixed oxidization system It is obtained after oxidation, eccentric cleaning and dialysis.
6. the preparation method according to claim 4, it is characterised in that: the polycation electrolyte in the step (2) Solution is chitosan/dilute acid soln, the polylysine aqueous solution of 0.1-1% or the organosilicon quaternary ammonium salt of 1-10% of 1-5% Aqueous solution.
7. the preparation method according to claim 4, it is characterised in that: the blood coagulation in the step (2) promotees to be cured the factor to be dense Degree is 0.1-10mg/mL collagen aqueous solution or the fibrin ferment of 0.01-1mg/mL.
8. the preparation method according to claim 4 or 7, it is characterised in that: blood coagulation in the step (2) promote to be cured the factor with The mass ratio of oxidizing bacteria cellulose is 1:1-10:1.
9. the preparation method according to claim 4, it is characterised in that: the dipping adsorption time in the step (2) is 0.5-5 hours.
10. the preparation method according to claim 4, it is characterised in that: the Electrostatic Absorption self assembly in the step (2) is anti- It is 1-60 minutes between seasonable.
CN201910842260.6A 2019-09-06 2019-09-06 A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose Pending CN110507844A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910842260.6A CN110507844A (en) 2019-09-06 2019-09-06 A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910842260.6A CN110507844A (en) 2019-09-06 2019-09-06 A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose

Publications (1)

Publication Number Publication Date
CN110507844A true CN110507844A (en) 2019-11-29

Family

ID=68631342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910842260.6A Pending CN110507844A (en) 2019-09-06 2019-09-06 A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose

Country Status (1)

Country Link
CN (1) CN110507844A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111171361A (en) * 2020-03-12 2020-05-19 黄旭萍 Bacterial cellulose composite membrane for medical dressing and preparation method thereof
CN111939314A (en) * 2020-07-28 2020-11-17 天津科技大学 A kind of preparation method of bacterial cellulose ointment for wound surface
CN112442200A (en) * 2020-11-29 2021-03-05 宁波工程学院 Preparation method of bacterial cellulose composite collagen self-assembly material
CN112773929A (en) * 2020-12-31 2021-05-11 东华大学 Absorbable hemostatic composite material based on polyanionic cellulose and preparation method thereof
CN113384736A (en) * 2021-06-25 2021-09-14 东华大学 Pullulan-zinc oxide hybrid nanofiber/bacterial cellulose composite functional dressing and preparation method thereof
CN114369291A (en) * 2021-12-31 2022-04-19 深圳大学 Method for constructing blood vessel model in vitro and blood vessel model
CN114381826A (en) * 2022-01-19 2022-04-22 深圳大学 Bacterial cellulose porous fiber and preparation method and application thereof
CN114681656A (en) * 2020-12-31 2022-07-01 苏州博创同康生物工程有限公司 Antibacterial and repairable absorbable composite polysaccharide biomaterial and preparation method and application thereof
CN115089709A (en) * 2022-06-24 2022-09-23 华中科技大学 Multifunctional hydrogel with photothermal and immunotherapy effects, and preparation and application thereof
CN115778678A (en) * 2022-11-21 2023-03-14 山东叶之梦智能科技有限公司 Preparation method of degradable sanitary towel
CN115957368A (en) * 2022-12-20 2023-04-14 重庆大学附属肿瘤医院 Bacterial cellulose membrane for repairing skin wound and preparation method and application thereof
CN116370695A (en) * 2023-03-17 2023-07-04 东华大学 Absorbable hemostatic composite material for anti-inflammation and promoting healing of acute bleeding site and preparation method thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134293A1 (en) * 2005-02-09 2007-06-14 Huey Raymond J Devices and methods for the delivery of blood clotting materials to bleeding wounds
CN102178973A (en) * 2010-01-15 2011-09-14 东华大学 Bacterial cellulose based antibacterial dry film for treating acute injury and preparation method and application thereof
WO2011119878A1 (en) * 2010-03-25 2011-09-29 Tyco Healthcare Group Lp Functionalized adhesive for medical devices
CN105536039A (en) * 2015-12-25 2016-05-04 北京大清生物技术有限公司 Hemostatic material capable of absorbing fluid and preparation method and application thereof
CN106178066A (en) * 2015-05-07 2016-12-07 中国科学院化学研究所 A kind of modified cellulose/chitosan compound hemostatic material and preparation method and application
US20170312398A1 (en) * 2014-11-24 2017-11-02 Biotronik Ag Method for producing a storable molded body made of bacterial cellulose and a molded body produced according to the method
CN108379644A (en) * 2018-03-03 2018-08-10 青岛大学 A kind of preparation method for the efficient hemostatic material being suitable for open drowned wound
US20190062998A1 (en) * 2016-02-24 2019-02-28 Ecoinno (H.K.) Limited Cellulose materials and methods of making and using same
CN110141677A (en) * 2019-06-06 2019-08-20 东华大学 Absorbable material for local acute hemostasis and preparation method thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134293A1 (en) * 2005-02-09 2007-06-14 Huey Raymond J Devices and methods for the delivery of blood clotting materials to bleeding wounds
CN102178973A (en) * 2010-01-15 2011-09-14 东华大学 Bacterial cellulose based antibacterial dry film for treating acute injury and preparation method and application thereof
WO2011119878A1 (en) * 2010-03-25 2011-09-29 Tyco Healthcare Group Lp Functionalized adhesive for medical devices
US20170312398A1 (en) * 2014-11-24 2017-11-02 Biotronik Ag Method for producing a storable molded body made of bacterial cellulose and a molded body produced according to the method
CN106178066A (en) * 2015-05-07 2016-12-07 中国科学院化学研究所 A kind of modified cellulose/chitosan compound hemostatic material and preparation method and application
CN105536039A (en) * 2015-12-25 2016-05-04 北京大清生物技术有限公司 Hemostatic material capable of absorbing fluid and preparation method and application thereof
US20190062998A1 (en) * 2016-02-24 2019-02-28 Ecoinno (H.K.) Limited Cellulose materials and methods of making and using same
CN108379644A (en) * 2018-03-03 2018-08-10 青岛大学 A kind of preparation method for the efficient hemostatic material being suitable for open drowned wound
CN110141677A (en) * 2019-06-06 2019-08-20 东华大学 Absorbable material for local acute hemostasis and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
方达通等: "细菌纤维素-透明质酸-聚赖氨酸复合膜的制备及其用于功能敷料的潜力", 《纤维素科学与技术》 *
贾原媛等: "细菌纤维素生物医学材料的性能改进", 《天津科技大学学报》 *
赵松林等: "(四)细菌纤维素的应用", 《椰子综合加工技术》 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111171361A (en) * 2020-03-12 2020-05-19 黄旭萍 Bacterial cellulose composite membrane for medical dressing and preparation method thereof
CN111939314A (en) * 2020-07-28 2020-11-17 天津科技大学 A kind of preparation method of bacterial cellulose ointment for wound surface
CN112442200A (en) * 2020-11-29 2021-03-05 宁波工程学院 Preparation method of bacterial cellulose composite collagen self-assembly material
CN114681656A (en) * 2020-12-31 2022-07-01 苏州博创同康生物工程有限公司 Antibacterial and repairable absorbable composite polysaccharide biomaterial and preparation method and application thereof
CN112773929A (en) * 2020-12-31 2021-05-11 东华大学 Absorbable hemostatic composite material based on polyanionic cellulose and preparation method thereof
CN113384736A (en) * 2021-06-25 2021-09-14 东华大学 Pullulan-zinc oxide hybrid nanofiber/bacterial cellulose composite functional dressing and preparation method thereof
CN114369291A (en) * 2021-12-31 2022-04-19 深圳大学 Method for constructing blood vessel model in vitro and blood vessel model
CN114381826A (en) * 2022-01-19 2022-04-22 深圳大学 Bacterial cellulose porous fiber and preparation method and application thereof
CN114381826B (en) * 2022-01-19 2023-05-12 深圳大学 Bacterial cellulose porous fiber and preparation method and application thereof
CN115089709A (en) * 2022-06-24 2022-09-23 华中科技大学 Multifunctional hydrogel with photothermal and immunotherapy effects, and preparation and application thereof
CN115089709B (en) * 2022-06-24 2023-08-25 华中科技大学 Multifunctional hydrogel with photothermal and immunotherapeutic effects and its preparation and application
CN115778678A (en) * 2022-11-21 2023-03-14 山东叶之梦智能科技有限公司 Preparation method of degradable sanitary towel
CN115957368A (en) * 2022-12-20 2023-04-14 重庆大学附属肿瘤医院 Bacterial cellulose membrane for repairing skin wound and preparation method and application thereof
CN115957368B (en) * 2022-12-20 2024-04-12 重庆大学附属肿瘤医院 Bacterial cellulose membrane for repairing skin wounds and preparation method and application thereof
CN116370695A (en) * 2023-03-17 2023-07-04 东华大学 Absorbable hemostatic composite material for anti-inflammation and promoting healing of acute bleeding site and preparation method thereof

Similar Documents

Publication Publication Date Title
CN110507844A (en) A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose
CN112300420B (en) An injectable antibacterial interpenetrating double network hydrogel and its preparation method and application
Zhang et al. Application status and technical analysis of chitosan-based medical dressings: a review
CN110141677B (en) Local acute hemostasis absorbable material and preparation method thereof
Wang et al. Multifunctionalized alginate/polydopamine cryogel for hemostasis, antibacteria and promotion of wound healing
CN102961777B (en) Method for preparing porous compound type high permeability absorption hemostasis coating with modified nano-crystalline cellulose
CN113769156B (en) Hybrid fiber sponge with functions of hemostasis and wound repair and preparation method thereof
CN101224310A (en) A medical wound dressing loaded with antibacterial drug nanoparticles
CN106178066A (en) A kind of modified cellulose/chitosan compound hemostatic material and preparation method and application
CN105228658A (en) A kind of medical dressing hydrogel compound fabric and its preparation method and application
CN104474576B (en) Chitosan hemostatic material formed by covalent crosslinking and preparation method thereof
Wang et al. Tissue adhesives based on chitosan for skin wound healing: Where do we stand in this era? A review
CN116271204B (en) A clay mineral-based hemostatic, antibacterial and healing-promoting hydrogel and preparation method thereof
CN111617308A (en) A kind of antibacterial medical hemostatic sponge and preparation method thereof
CN115645597A (en) Silk fibroin hemostatic gel and preparation method and application thereof
CN112773929A (en) Absorbable hemostatic composite material based on polyanionic cellulose and preparation method thereof
CN113908328B (en) An antibacterial and hemostatic porous microsphere based on sodium alginate and nanocrystalline cellulose
CN116440317A (en) Photothermal antibacterial hydrogel and preparation method thereof
CN102940903B (en) Method for preparing medical dressing of polysaccharide cavernous body
CN1810298A (en) Bacteriostatic porous polyelectrolyte material and its prepn process
CN118001450A (en) Chitosan/quaternized chitosan sponge and preparation method and application thereof
CN113908330B (en) Preparation method of composite gel with photothermal antibacterial hemostatic characteristics, product and application thereof
CN114191601B (en) A starch gel hemostatic material based on 3D printing technology and its preparation method and application
Tian et al. Injectable self-healing hydrogels loaded with Crinis Carbonisatus nanoparticles for rapid hemostasis and wound healing
CN103174017B (en) Sodium alginate oxide modified chitosan fiber and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination